ESMO 2024 - Overall Survival Data from the KEYNOTE-522 Trial with Dr. Peter Schmid

Watch Now ESMO 2024 - Overall Survival Data from the KEYNOTE-522 Trial with Dr. Peter Schmid

ESMO 2024 - Daily RECAP day 1

Watch Now ESMO 2024 - Daily RECAP day 1

ESMO 2024 - Global Speaker Series - Dr. Nancy Lin on ESMO LBA18: Trastuzumab deruxtecan (T-DXd) in patients with HER2+ advanced/mbc & DESTINYBreast-12 primary results

Watch Now ESMO 2024 - Global Speaker Series - Dr. Nancy Lin on ESMO LBA18: Trastuzumab deruxtecan (T-DXd) in patients with HER2+ advanced/mbc & DESTINYBreast-12 primary results

ESMO 2024 - Global Speaker Series - Dr. Alnouri Highlights What to Expect at ESMO 2024: Advances in Breast Cancer

Watch Now ESMO 2024 - Global Speaker Series - Dr. Alnouri Highlights What to Expect at ESMO 2024: Advances in Breast Cancer

ESMO 2024 - Global Speaker Series - De-escalation Strategies in HER2+ Early-Stage Breast Cancer with Dr. Carlos A. Gonzalez Nuñez MD

Watch Now ESMO 2024 - Global Speaker Series - De-escalation Strategies in HER2+ Early-Stage Breast Cancer with Dr. Carlos A. Gonzalez Nuñez MD